SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MorphoSys AG (MOR)
An SI Board Since January 2000
Posts SubjectMarks Bans
421 15 0
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
221Large Research Antibody Order from Proteomics Specialist Proteomika 03/05/2008 Germanecki-3/11/2008
220Increase of Revenues, Operating Profit and Net Income MorphoSys AG Reports FinaGermanecki-3/11/2008
219Sigma-Aldrich And MorphoSys AG To Collaborate For Developing And Distributing ReGermanecki-2/27/2008
218MorphoSys and Astellas Extend Alliance for Use of HuCAL GOLD to Develop Novel AnGermanecki-2/21/2008
217Morphosys "buy," target price raised Wednesday, January 30, 2008 6:23Germanecki-1/30/2008
216Deutsche Bank: One step before takeout 29 January 2008 One step before takeoutGermanecki-1/30/2008
215MorphoSys Discloses GM-CSF as Target of MOR103 Program 01/16/2008 at 07:30 AM Germanecki-1/16/2008
214NIDDK Scientists Detect New Epitope on HIV-1 Protein gp41 Using AbD Serotec-geneGermanecki-1/9/2008
213MorphoSys Files Clinical Trial Application to Initiate First Phase 1 Clinical StGermanecki-12/28/2007
212MorphoSys Broadens Scope of Collaboration with GeneFrontier 12/10/2007 at 07:38Germanecki-12/10/2007
211MorphoSys lands $1B-plus deal with Novartis Monday, December 3, 2007 - 11:41 AMGermanecki-12/3/2007
210MorphoSys and Novartis Forge New Strategic Alliance to Establish Innovative Therscaram(o)uche-12/2/2007
209MorphoSys Announces Development of New Antibody Platform Technology MARTINSRIED,Germanecki-11/20/2007
208Dyax and MorphoSys Sign License Agreement on Antibody-Related Patents 20.11.20Germanecki-11/20/2007
207MorphoSys Reports Nine Months 2007 Results 10/25/2007 at 07:30 AM MorphoSys AGermanecki-10/25/2007
206MorphoSys Enters Therapeutic Research Collaboration on Novel Target Molecule witGermanecki-10/8/2007
205Johnson&Johnson Daughter Centocor was the third mAb in clinic with MorphosysGermanecki-10/4/2007
204MorphoSys Granted Further U.S. Patent for Its Core Antibody Technology HuCAL Wedscaram(o)uche-9/26/2007
203Only three years from start of collaboration to the clinic! Impressing.Germanecki-9/18/2007
202MorphoSys Announces Clinical Milestone in Antibody Program -- Fourth HuCAL-basedscaram(o)uche-9/18/2007
201MorphoSys Reports Six Months 2007 Results07/30/2007 at 07:30 AM MorphoSys AG (Germanecki-8/2/2007
200MorphoSys Announces Clinical Milestone in Partnered Therapeutic Antibody ProgramGermanecki-6/21/2007
199MorphoSys Reports Completion of Equity Issue 05/03/2007 at 12:19 PM MorphoSysGermanecki-5/10/2007
198MorphoSys Launches Share Capital Issuance 05/02/2007 at 19:03 PM MorphoSys AGGermanecki-5/10/2007
197MorphoSys Reports First Quarter 2007 Results 04/26/2007 at 07:30 AM MorphoSysGermanecki-5/4/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News